1. Introduction {#s0005}
===============

In humans and most animal models, development of obesity also leads to ectopic adipose tissue storage ([@bb0010]). Normal renal sinus (RS) contains a small amount of adipose tissue that lines other structures within it. By excess deposition of perirenal adipose tissue in the RS, compression of various renal structures may occur, especially the inner medulla that, unlike the entire kidney, is not protected by the fibrous capsule ([@bb0145]). It has been previously shown that RS adipose tissue may have an independent association with renal functions ([@bb0035], [@bb0060]). However, RS adipose tissue research is limited to only a couple of recently published studies. Foster et al. ([@bb0060]) showed that RS adipose tissue is associated with an increased risk of hypertension and chronic renal disease. Similarly, Chughtai et al. ([@bb0035]) indicated that RS adipose tissue volume was associated with the number of prescribed antihypertensive medications and stage II hypertension.

Overall, obesity can lead to renal functional disorders and induce hypertension through a variety of mechanisms: ([@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0095], [@bb0090]). Activation of sympathetic nervous system; Physical--mechanical compression; Renin--angiotensin--aldosterone system. It has been hypothesized that RS adipose tissue effect is local and mostly occurs through the physical--mechanical compression ([@bb0165], [@bb0090]). However, unfortunately exact mechanisms how RS adipose tissue could influence kidney functions are not described. Additionally, published RS adipose tissue research has some significant disadvantages. Since the object segmentation and 3D reconstruction of organs is labor-intensive and time-consuming, often chosen strategy is computed tomography (CT) or magnetic resonance (MR) single-scan measurement at a specific anatomic level. In this way, the manual data processing is reduced significantly. However, as the RS adipose tissue is a small and diffuse object, this also results in loss of the measurement quality. Since RS adipose tissue compartment is relatively small object, then in our study, strategy to segment the entire RS adipose tissue and analyze it\'s full volumes, was used, thus more accurately characterizing RS adipose tissue and it\'s role.

In our study we analyze asymptomatic, middle age participants, therefore, it was important to find an earlier diagnostic biomarkers of kidney injury. It is useful to keep in mind that creatinine level may not raise until more than half of the kidney function has been lost due to renal reserve. Kidney injury factor (KIM)-1 serves as an earlier diagnostic biomarker of kidney injury when compared to any of the conventional diagnostic markers, e.g., serum creatinine and cystatin C, increased proteinuria. It has been approved by the US Food and Drug Administration as an acute kidney injury biomarker for preclinical drug development ([@bb0040]). KIM-1 expression and secretion was observed in the kidney epithelial cells in vitro ([@bb0115]), in animal models and in patients with various kidney diseases ([@bb0155]). Experiments in rodents and studies in humans have shown that kidney ischemia or hypoxia promotes KIM-1 concentrations increase in the urine and blood serum. Chronic KIM-1 expression can promote further tubulointestinal inflammation and hypoxia, further inducing KIM-1 expression that culminate in chronic kidney disease ([@bb0105]). The ectodomain of KIM-1 is shed into the lumen, and serves as a urinary biomarker of kidney injury ([@bb0015], [@bb0140], [@bb0125]). Recent study showed that KIM-1 may be released into the circulation and identified KIM-1 as a blood biomarker that specifically reflects injury to the proximal tubule of the kidney, the primary site of injury for ischemia and most nephrotoxicants ([@bb0180], [@bb0020]). The proposed mechanisms for the KIM-1 reabsorption are: (1) After kidney proximal tubule injury when tubular cell polarity is lost and KIM-1 may be released directly into the interstitium; (2) Renal microvascular endothelial cells are detached from the basement membrane that facilitate KIM-1 reabsorption into the circulation ([@bb0180]) ([@bb0090]).

Recently, fibroblast growth factor (FGF)-21 was introduced as a renal function marker. FGF-21 levels were higher in the patients with both chronic and acute renal dysfunctions. Additionally, FGF-21 levels gradually increased with the development or renal diseases from the early to late stage ([@bb0220]). FGF-21 serve as renal function marker because renal elimination is a major route by which physiological FGF-21 serum levels are maintained ([@bb0195]). Respectively, if renal function is impaired, serum FGF-21 level rise.

In general, there is limited information about the mechanism how RS adipose tissue induce renal disease and hypertension. There is no information about RS adipose tissue and early diagnostic biomarkers of kidney injury. Additionally, all previously conducted researches were based on RS adipose tissue single slice measurements. Thereby, the aim of the study was to quantify RS and abdominal adipose tissue volumes and to evaluate sKIM-1 (as primary kidneys damage marker) and FGF-21 association with different adipose tissue compartments in the observational study with a cross-sectional design and a prospective one-year naturalistic follow-up study. We hypothesized that RS adipose tissue would be independently associated with sKIM-1 and FGF-21 levels after accounting for abdominal adipose tissue segments (retroperitoneal (RP), intraperitoneal (IP) and subcutaneous (SC)) as a measure of abdominal obesity.

2. Methods {#s0010}
==========

2.1. Participants and Study Design {#s0015}
----------------------------------

An observational study with a cross-sectional design and a prospective one-year naturalistic follow-up study. The period of recruitment was from January 2011 till January 2014. The sample size was calculated according to proportions (*n* = 1.96^2^ × 4 p(1 − p)/d^2^; where: p -- expected population proportion; d - the desired width of the confidence interval (CI)). In our case: an estimate of the prevalence of adipose tissue accumulation in the RS is 0.99 (99%). The width of the 95% CI is 0.1. Estimated minimal sample size was 153 subjects.

The cross-sectional study participants were selected from family physician\'s practices of a Health care center in Riga. The exclusion criteria for the participants selection were a recorded diagnosis of chronic kidney diseases (nephrolithiasis; renal cysts; nephroptosis; an extra kidney; renal lipomatosis), cardiovascular diseases, thyroid diseases, diabetes or malignancy; use of tobacco and alcohol (male \> 140 g ethanol per week; female \> 70 g ethanol per week); anamnesis of arterial hypertension, pregnancy and lactation, taking any regular medications; body mass index (BMI) \< 18 kg/m^2^ and BMI \> 35 kg/m^2^. The inclusion criteria were BMI = 18--35 kg/m^2^, age 30--45 years. In the cross-sectional study 280 participants were recruited (144/136, F/M) aged 37.30 ± 4.10 years, ethnicity -- Caucasians.

Participants (*n* = 40; 20/20, F/M) for the prospective one-year naturalistic follow-up study were recruited from the cross-sectional study group. The inclusion criteria for this study were left RS ratio \> 0.025 (see [Section 2.3](#s0025){ref-type="sec"}). The participants were randomized into two groups: participants (10/10, F/M) randomized for the intervention received daily text messages for one year. Text messages included practical recommendations on how to balance caloric intake and physical activity to achieve and maintain a healthy body weight. The recommendations were prepared by the general practitioner according to the diet and lifestyle recommendations ([@bb0045]). Other randomized 10 males and 10 females did not receive any intervention for one year. The study design is shown in the [Fig. 1](#f0005){ref-type="fig"}.

Experimental procedures were approved by the Ethical Committee of the Institute of Experimental and Clinical Medicine, University of Latvia. All procedures performed in this study were in accordance with the ethical standards of the institutional and international research committee and with the 1964 Helsinki declaration. Informed consent was obtained from all study participants.

2.2. Anthropometric Parameters {#s0020}
------------------------------

BMI was calculated as the ratio of weight to height squared. Normal weight was defined as BMI 18.0--24.9 kg/m^2^; overweight -- as BMI 25.0--29.9 kg/m^2^ and obesity -- as BMI ≥ 30 kg/m^2^. Waist circumference (WC) was measured using a tape rule, and the point of measurement was the anterior superior iliac spine ([@bb0135]). Blood pressure (systolic blood pressure (SBP) and diastolic blood pressure (DBP)) measurements were performed by professional medical assistant.

2.3. Abdominal and RS Adipose Tissue Quantification {#s0025}
---------------------------------------------------

Native abdominal (\~ Th10 to \~ L4) CT scans were captured using spiral (128-slice configuration) CT SOMATOM Definition AS/AS (Siemens AG, Forchheim, Germany) with automated tube current modulation (CareDose4D, Siemens) during inspiratory breath-hold (slice thickness 5 mm). CT scans were post-processed using the 3D Doctor software (Able Software Corp., Lexington, MA, USA). According to the techniques and anatomical landmarks published previously ([@bb0035]), abdominal adipose tissue was manually segmented into SC, RP, and IP compartments ([Fig. 2](#f0010){ref-type="fig"}. c). Two abdominal adipose tissue measurement series were performed. First, total abdominal adipose tissue volume was measured at the level of both kidneys (*n* = 100) ([Fig. 2](#f0010){ref-type="fig"}a, A-1) for all compartments (RP~full,~ IP~full~, SC~full~). Second, CT measurements of abdominal adipose tissue was performed in three axial slices (RP~three-slices,~ IP~three-slices~, SC~three-slices~) ([Fig. 2](#f0010){ref-type="fig"}a, A-2) positioned at the level of the right renal hilum. Next, total volumetric RS adipose tissue segmentation from both kidneys were performed. According to the Foster et al. ([@bb0055], [@bb0060]) protocol, the boundary of RS was defined as a straight line between both dimples at the edge of the RS opening ([Fig. 2](#f0010){ref-type="fig"}a, A-1). Since RS adipose tissue compartment is relatively small object, strategy to segment the entire RS adipose tissue in the RS and analyze its full volumes was used, thus more accurately characterizing RS adipose tissue ([Fig. 2](#f0010){ref-type="fig"}d and f). Additionally, total volumetric kidney segmentation was performed (we excluded major branches of the renal artery and vein as well as any visible branches of the renal collecting system) ([@bb0035]). According to Glodny et al. ([@bb0065]) a kidney length (pole to pole) in the coronal plane and according to Breau et al. ([@bb0025]) sagittal and lateral diameter in the axial plane were measured ([Fig. 2](#f0010){ref-type="fig"}e).

Overall, for adipose tissue compartments and kidney volume detection, first, region of interest was manually outlined with the mouse by using a tool called "Polygon" on each section. Second, segmentation of adipose tissue and kidney volumes was performed based on Hounsfield units (HU). Adipose tissue was identified using an attenuation range of (− 195)--(− 45) HU ([@bb0055], [@bb0060]), for kidneys - (+ 20)--(+ 40) HU ([@bb0100]). Third, we used 3D Rendering Full Complex Surface command and constructed 3D models ([Fig. 2](#f0010){ref-type="fig"}d and f). Different adipose tissue compartment\'s volumes (cm^3^) were measured by volume and surface rendering technique according to which the 3D Doctor software calculates segmental volume of each respective adipose tissue compartment slice as the product the slice area and the inter-slice distance (slice thickness). The volume of the entire adipose tissue compartment was then calculated as a sum of segmental volumes as indicated by the Cavalieri\'s principle ([@bb0205]): the volume of the abdominal or the RS adipose tissue = Σ (volumes of all respective adipose tissue slices).

In order to exclude the kidney size effect on RS adipose tissue volume, ratio of RS adipose tissue volume to corresponding total kidney size was calculated using the arithmetical mean for each participant:$$\text{left}\ {RS}\ \text{ratio} = \frac{\text{left}\ {RS}\ \text{adipose\ tissue\ volume}}{\text{left\ kidney\ volume}}$$$$\text{right}\ {RS}\ \text{ratio} = \frac{\text{right}\ {RS}\ \text{adipose\ tissue\ volume}}{\text{right\ kidney\ volume}}$$

The participants for the prospective one-year naturalistic follow-up study were recruited from the cross-sectional study group according to 75th percentile of the left RS ratio (75th percentile = 0.025). The left RS ratio was chosen because the left RS accumulates significantly higher amount of adipose tissue compared to the right RS (see [Section 3.4](#s0060){ref-type="sec"}).

2.4. Analytical Methods {#s0030}
-----------------------

sKIM-1 level was measured by Human Kidney Toxicity Magnetic Bead Panel 1, HKTX1MAG-38K (Millipore, Billerica, MA, USA), interleukin (IL)-6 and tumor necrosis factor alpha (TNFα) were measured by HADCYMAG-61 (Millipore, Billerica, MA, USA) on a Luminex 200 analyzer (Austin, TX, USA). FGF-21 was measured by ELISA kits (\#EZHFGF21-19K; Millipore, Billerica, MA, USA) on an Infinite®M200 analyzer (Tecan Trading AG, Switzerland). The tests were performed in accordance with the manufacturer\'s instructions. Serum creatinine, cystatin C, glucose, triglycerides (TG), high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) tests were performed in the clinical laboratory 'E.Gulbja laboratorija', Riga, Latvia. The estimated glomerular filtration rate (eGFR~EPI\ cyst&crea~) was determined using cystatin C and creatinine concentrations and Chronic Kidney Disease Epidemiology equation ([@bb0120]).

Venous blood samples for blood tests were collected without anticoagulant and were allowed to coagulate for 25--30 min at the room temperature. After that, samples were centrifuged at 4 °C for 10 min at 1600 ×* g*. All specimens were immediately aliquoted, frozen, and stored at − 80 °C until use (for serum sKIM-1 and FGF-21 analysis; standard blood tests were performed using fresh serum samples). Serum samples were obtained after an overnight fast.

2.5. Statistical analysis {#s0035}
-------------------------

For the cross-sectional study the fatty kidney group was defined as the presence of high left RS ratio based on gender specific 75th percentiles (Control group \< 75th percentiles). For the prospective one-year naturalistic follow-up study we divided all (*n* = 40) participants in the three groups according to the significant (\> 5%) visceral adipose tissue (IP adipose tissue + RP adipose tissue) volume change after follow-up period: Group 1 (control) -- no significant visceral adipose tissue volume change; Group 2 - significant visceral adipose tissue volume decrease; Group 3 - significant visceral adipose tissue volume increase.

Data were analyzed using SPSS22.0. After testing normality (Kolmogorov-Smirnov test) unpaired data with normal distribution (presented as mean ± SD) were analyzed using unpaired Student *t*-test. Mann-Whitney *U* test was used as nonparametric method for unpaired data (data with skewed distribution presented as median and interquartile range). p \< 0.05 was considered significant. Paired data (left vs. right RS ratio, left vs. right kidney and follow up study\'s data (baseline vs. end)) were compared using Wilcoxon rank-sum test. Square root transformation (sqrt) was used for positive skew data, when Pearson and age and gender adjusted partial Pearson correlations as well as multiple linear regression analysis were performed. Pearson correlation was used to detect association between different abdominal and RS adipose tissue compartments. Associations between sKIM-1 or FGF-21 and different adipose tissue compartments were assessed by an age and gender adjusted stepwise-method multiple linear regression analysis (results presented as standardized regression coefficient (β); 95% CI; R^2^% and p value). Collinearity was assessed using variance inflation factor (VIFs) and tolerance (VIF \> 10.0 and tolerance \< 0.2 indicating model instability). Binary logistic regression was used to calculate age and gender adjusted p values. All adipose tissue compartments were measured separately by two readers for inter-reader variation and then repeated by the first reader for intra-reader variation. Bland-Altman plots were utilized to assess potential systematic biases within the intra-reader and inter-reader repeated measurements.

3. Results {#s0040}
==========

The [3.1](#s0045){ref-type="sec"}, [3.2](#s0050){ref-type="sec"}, [3.3](#s0055){ref-type="sec"}, [3.4](#s0060){ref-type="sec"}, [3.5](#s0065){ref-type="sec"} summarize the cross-sectional study results.

3.1. General Characteristics of Participants {#s0045}
--------------------------------------------

RS adipose tissue volume ranged from 0.07 cm^3^ to 11.23 cm^3^. Individuals with fatty kidney had a higher BMI, higher level of serum KIM-1, FGF-21 and TG levels, as well as significantly lower LDLC level ([Table 1](#t0005){ref-type="table"}). However, WC and BMI adjusted binary logistic regression shows that serum TG level is positively associated with IP adipose tissue segment volume (effect size 56%, p \< 0.01). In general males had significantly greater (p \< 0.05) WC and higher visceral adipose tissue (RP and IP) accumulation. However, amount of SC adipose tissue is significantly higher in females. These results are in agreement with those reported previously. Concerning to the inflammatory cytokine levels there are no significant difference between control and fatty kidney group ([Table 1](#t0005){ref-type="table"}). Participant\'s eGFR~EPI\ cyst&crea~ was \> 60 ml/min/1.73 m^2^ ([Table 1](#t0005){ref-type="table"}).

3.2. Abdominal Adipose Tissue Measurements {#s0050}
------------------------------------------

Abdominal adipose tissue compartments measured in full volumetric measurement along kidney ([Fig. 2](#f0010){ref-type="fig"}a, A-1) and three-slices ([Fig. 2](#f0010){ref-type="fig"}a, A-2) at the level of renal hilum, showed strong Pearson correlation coefficients for both males (RP~full~ and RP~three-slices~, *r* = 0.93; IP~full~ and IP~three-slices~, *r* = 0.91; SC~full~ and SC~three-slices~, *r* = 0.83; p \< 0.001) and females (RP~full~ and RP~three-slices~, *r* = 0.95; IP~full~ and IP~three-slices~, *r* = 0.98; SC~full~ and SC~three-slices~, r = 0.98; p \< 0.001) participants. The results suggest, that three slice abdominal adipose tissue measurements at the level of the right renal hilum ([Fig. 2](#f0010){ref-type="fig"}a, A-1) completely represent IP, RP and SC adipose tissue relative quantity at the kidney region ([Fig. 2](#f0010){ref-type="fig"}f). Additionally, since RS is connected with a perinephric space only at the level of a renal hilum then for further data analysis three sliced abdominal adipose tissue measurements are used. Three- slice abdominal adipose tissue compartment volumes are given in [Table 1](#t0005){ref-type="table"}.

3.3. Kidney Size Measurements {#s0055}
-----------------------------

[Table 2](#t0010){ref-type="table"} shows that females kidney (left and right) volumes are significantly (p \< 0.001) lower than males. For both genders no significant differences between the right and left kidney volume are found. However, for both males and females right kidney shows significant higher sagittal diameter and significant lower lateral diameter compared to the left kidney ([Table 2](#t0010){ref-type="table"}). Consequently, the left kidney is slightly laterally flattened which is compensated with a sagittal diameter increase.

3.4. Measurements of RS Adipose Tissue {#s0060}
--------------------------------------

Anatomically, RS adipose tissue can be described as diffuse structure which in a "drop-like" manner is situated between other structures in the RS ([Fig. 2](#f0010){ref-type="fig"}d and f). RS adipose tissue volumes in the left and the right kidney were 2.7 (1.49 to 4.62) cm^3^ and 1.07 (0.46 to 2.45) cm^3^, respectively, in males and 1.39 (0.57 to 2.99) cm^3^ and 0.39 (0.10 to 0.95) cm^3^, respectively, in females participants.RS adipose tissue volume shows no significant (p \> 0.05) correlation corresponding to respective (right or left) kidney volume for neither gender. However, to be able to effectively compare females and males RS adipose tissue, as well as to exclude the possibility that in some cases kidney volume could affect RS adipose tissue volume, further cross-sectional study data analysis and interpretation is done by using relative ratio - RS adipose tissue volume corresponding to kidneys (right or left) volume.

All participants (*n* = 280) regardless of gender, accumulate significantly more (p \< 0.001) adipose tissue in the left RS ([Fig. 3](#f0015){ref-type="fig"}). Additionally, the same asymmetric distribution pattern of adipose tissue we find for participants with high normal blood pressure (Supplemental material Table S1.) and patients with bilateral nephrolithiasis (Supplemental material Table S2.). Moreover, both participants with the high normal blood pressure in comparison to the participants with the optimal blood pressure and patients with bilateral nephrolithiasis in comparison to the asymptomatic participants show statistically higher adipose tissue accumulation both in the left and the right RS (Supplemental material Tables S1 and S2.).

Age and gender adjusted correlations of RS ratio with adiposity measures and continuous covariates are presented in [Table 3](#t0015){ref-type="table"}.

RS ratio was correlated with all of the adipose tissue and anthropometric measurements covariates examined (p \< 0.001) except SBP and DBP (p \> 0.05), with the strongest correlations observed for other RP adipose tissue measures. Only sKIM-1 and FGF-21 was correlated with RS ratio according to the kidney biochemical parameters (p \< 0.05). Additionally, RS ratio increase was associated with an increased TG level and decreased LDLH level. Concerning to the inflammatory cytokine levels neither left RS ratio nor right RS ratio showed significant association with inflammatory cytokine levels. It is possible that smaller adipose tissue compartments, like the RS adipose tissue one, could be devoid of systemic inflammatory effects.

Intra-([Fig. 4](#f0020){ref-type="fig"}a) and inter-([Fig. 4](#f0020){ref-type="fig"}b) reader reproducibility of RS adipose tissue measurement are shown in the Bland-Altman plots. Overall, the mean difference between the repeated measurements was 0.001 cm^2^ with upper and lower confidence limits of 0.442 cm^2^ and − 0.430 cm^2^, respectively, suggesting minimal systematic bias between the intra-reader measurements. For the inter-reader measurements the mean difference between repeated measures was 0.005 cm^2^, with upper and lower confidence limits of 0.481 cm^2^ and − 0.497 cm^2^. Linear multiple regression analysis shows that there is no proportional bias in intra-(p = 0.49) or inter-reader (p = 0.71) measurements.

3.5. RS Adipose Tissue Association With Serum KIM-1 and FGF-21 Level {#s0065}
--------------------------------------------------------------------

sKIM-1 and FGF-21 levels were significantly higher for the fatty kidney group compared to the control group ([Table 1](#t0005){ref-type="table"}). After grouping of study participants into three groups according to left ([Fig. 5](#f0025){ref-type="fig"}a and c) or right ([Fig. 5](#f0025){ref-type="fig"}b and d) RS ratio quartiles sKIM-1 and FGF-21 levels were significantly (p \< 0.05) higher in the Q~4~ (\> 75th) quartile group for both males and females.

We also performed an age and gender adjusted stepwise multivariable linear regression analysis using sKIM-1 or FGF-21 level as a dependent variable and all abdominal adipose tissue compartments as well as BMI and WC as predictors. The significant association between sKIM-1 level and right RS ratio was lost (β = 0.06; p = 0.750) but there remained a persistent association between the left RS ratio and sKIM-1 level for both males (β = 0.43; 95% CI (0.19 to 0.65); R^2^ = 29%; p = 0.009) and females (β = 0.38; 95% CI (0.15 to 0.47); R^2^ = 26%; p = 0.023). Significant association between sKIM-1 level and abdominal adipose tissue segments (IP, RP and SC), BMI and WC were not found. Significant positive association between FGF-21 level and left RS ratio + RP adipose tissue was found for both males (β = 0.56; 95% CI (0.29 to 0.72); R^2^ = 30%; p = 0.009) and females (β = 0.61; 95% CI (0.24 to 0.77); R^2^ = 34%; p = 0.023). Additionally, eGFR~EPI\ cyst&crea~ negatively predicts FGF-21 concentration in multiple regression analyses (β = − 0.31; 95% CI (0.11 to 0.54); R^2^ = 34%; p = 0.023) for both genders (FGF-21 level as a dependent variable and eGFR~EPI\ cyst&crea~ as well as cystatin C and creatinine as predictors). There was no collinearity between independent variables: VIF \< 5 and tolerance \> 0.2.

3.6. Follow-up Study Results {#s0070}
----------------------------

There was no statistically significant benefit of text messaging intervention in obese participants. [Table 4](#t0020){ref-type="table"} represents general characteristics, abdominal adipose tissue measurements, FGF-21 and sKIM-1 levels for males and females at the baseline and the end of the follow-up study (age and gender adjusted p values were not significant (p \> 0.05) -- data not shown in the [Table 4](#t0020){ref-type="table"}).

Main results of the one year follow-up study show that, compared to the control group, significant (\> 5%) increase in total amount of visceral adipose tissue also induce significant (p \< 0.05) increase in amount of adipose tissue in the left ([Fig. 6](#f0030){ref-type="fig"}a) or the right ([Fig. 6](#f0030){ref-type="fig"}b) RS. However, when significant (\> 5%) decrease in total amount of visceral adipose tissue is observed, there is not significant (p \> 0.05) decrease in amount of adipose tissue in the left ([Fig. 6](#f0030){ref-type="fig"}a) or the right ([Fig. 6](#f0030){ref-type="fig"}b) RS. In general the right and the left RS adipose tissue are positively associated with visceral adipose tissue amount ([Table 5](#t0025){ref-type="table"}).

The aim of the follow-up study was to confirm the cross-sectional study data: whether sKIM-1 and FGF-21 levels are associated with the change of RS adipose tissue or abdominal adipose tissue amount. Therefore, we calculated percentage change from baseline for all the adipose tissue segments (ΔSC, ΔIP, ΔRP, Δleft RS and Δright RS adipose tissue) as well as for sKIM-1 and FGF-21 level (ΔsKIM-1 and ΔFGF-21). RS adipose tissue volume shows no significant (p \> 0.05) correlation with the corresponding (right or left) kidney volume for neither gender in the cross-sectional study, therefore, RS adipose tissue volumes were taken for analysis. ΔsKIM-1 shows significant positive Spearman correlation with the Δleft and the Δright RS adipose tissue. Accordingly, both the cross-sectional and the one year follow-up study indicates positive association between sKIM-1 level and increase in amount of adipose tissue in the renal sinus. The abdominal adipose tissue segments (ΔSC, ΔIP, ΔRP) did not show significant association with change in ΔsKIM-1 serum level ([Table 6](#t0030){ref-type="table"}). ΔFGF-21shows significant positive Spearman correlation with the Δleft RS and RP adipose tissue amount. These results also confirms cross-sectional study results.

4. Discussion {#s0075}
=============

To the best of our knowledge findings reported in this study add some aspects to the function of RS adipose tissue. First, results indicate asymmetrical deposition of adipose tissue into the RS even after corresponding kidney volume adjustment in both males and females. Second, the cross-sectional and the follow-up studies shows that sKIM-1 level is positively associated with RS adipose tissue volume increase for both genders. Third, FGF-21 is associated with RS and RP adipose tissue amount and shows inverse association with GFR. Fourth, follow up study shows that accumulation of adipose tissue in the RS is related with the visceral adipose tissue volume increase. Additionally, significant visceral adipose tissue volume increase is related with significant increase of adipose tissue amount in the RS. However, significant visceral adipose tissue volume decrease does not show significant decrease of adipose tissue amount in the RS. From this we can draw a hypothesis that the RS adipose tissue accumulation happens faster than elimination.

Interestingly, that the left RS accumulate significantly more adipose tissue than the right RS for both genders. Moreover, we did not find association between kidney size and RS adipose tissue volume. To the best of our knowledge, this anatomical phenomenon previously has not been described. One of the reason could be, that since the object segmentation and 3D reconstruction of RS adipose tissue compartment is labor-intensive and time-consuming, often chosen strategy is CT or MR single slice cross-sectional area measurement at a specific anatomic level ([@bb0055], [@bb0035], [@bb0215]) or RS adipose tissue volume detection only in one kidney ([@bb0055], [@bb0060]). This way data processing time is significantly optimized, however, this also results in loss of measurement quality. Based on the results can be said that the RS adipose tissue compartments are a diffuse object that have "drop-like" form and are located between major and minor renal calices. Therefore, using only one scan could lead to inaccurate result that does not represent total amount of adipose tissue in the RS. Also fact that normal humans have two kidneys, therefore, two RS, must be taken into account when making measurements. Since humans are not bilaterally symmetrical (especially when talking about abdominal organs) and kidneys have both functional as well as anatomical asymmetry described, then it is important to analyze both RS.

We speculate that, first, asymmetrical RS adipose tissue accumulation could be result of anatomical differences between left and right renal vein. The right renal vein receives blood only from the right kidney, but the left renal vein receives left gonadal and adrenal veins in addition to the vein coming from the left kidney ([@bb0005]). There is no difference in diameter between the left and the right renal vein ([@bb0190]) but possibly this asymmetry predispose the left RS for higher RS adipose tissue deposition. Second, there is wide variation in calyceal orientation ([@bb0160]) According to the Kaye and Reinke results ([@bb0130]), the calyceal angles in the right and the left kidney differs.

The concept of anatomical, physiological, and functional asymmetry between kidneys has been a matter of interest for researchers. Clinicians recommend that functional asymmetry of the kidneys should be investigated preoperatively to determine which kidney should be donated and transplanted ([@bb0185]). Although, we did not find information about asymmetric RS deposition, considerable differences in renal blood flow have been reported between the right and the left kidneys in some previous investigations. Van Onna and co-authors showed that asymmetry of renal blood flow was present in up to 51% of hypertensive patients. Moreover, mean left renal blood flow was on average significantly lower than the right mean renal blood flow ([@bb0210]). Similar, Caralps et al. reported that in 10 out of 11 asymmetry cases the left kidney was more affected than the right one ([@bb0030]). Van Onna and co-authors showed that there is no association between kidney volume and asymmetry of renal blood flow in their study subjects ([@bb0210]). We hypothesized that significant higher RS adipose tissue deposition in the left kidney possibly could be inborn structural phenomenon that might cause asymmetrical renal blood flow.

Results of this study show that sKIM-1 level is positively associated with the RS adipose tissue volume increase for both males and females. In normal kidney proximal tubules KIM-1 are expressed at a very low level ([@bb0115]). However, its expression is significantly increased in the post-ischemic kidney ([@bb0110]). Jin and co-authors in their study detected sKIM-1 level (126.2 ± 53.5 pg/ml) for healthy middle age control subjects ([@bb0125]). Our study showed comparable average sKIM-1 concentrations for females and males in RS ratio quartile Q~1~ (63.56 (41.67 to 98.11) pg/ml and 79.20 (41.67 to 111.55) pg/ml, respectively). However, significant sKIM-1 level increase in the RS ratio quartile Q~4~ was observed. We propose that one of the initial mechanisms for obesity-induced renal damage and hypertension could be linked to proximal convoluted tubule epithelial cell damage caused by RS adipose tissue produced compression of intrarenal collecting system, blood and lymph vessel. As the left RS accumulate significantly more adipose tissues than the right RS, possibly, early changes could be observed directly in the left kidney. Together these findings indicate that there is some structural and functional asymmetry between deposition of adipose tissue in the right and the left RS.

In agreement with other studies ([@bb0195], [@bb0220], [@bb0150]) serum levels of the FGF-21 depend on renal functions because renal elimination is a major route by which physiological FGF-21 serum levels are maintained. Like other researches ([@bb0195], [@bb0150]) we found that GFR is significantly and inversely associated with circulating FGF-21 level. Furthermore, the cross-sectional and follow-up study confirms that FGF-21 level was positively associated with the RS and RP adipose tissue amount. We hypothesized that this association could be due to brown adipose tissue accumulation, respectively, RS and RP adipose tissues has different morphological profile compared with the IP and SC adipose tissues. Brown adipose tissue presence in the perirenal adipose tissue compartment was confirmed with biopsies from healthy kidney donors ([@bb0200]) and with a positron emission tomography/CT investigations ([@bb0170]). Ouellet et al. confirmed brown adipose tissue presence in perirenal fat compartment in a large cohort of patients (*n* = 4842) ([@bb0175]). Another research on mice suggested that perirenal adipose tissue compartment contains a mixture of brown and white adipose tissue ([@bb0050]). Accumulation of brown adipose tissue in RS could induce compression of various renal structures described before ([@bb0165], [@bb0060], [@bb0035]). However, effect of brown adipose tissue on serum lipoprotein level could be favorable. This is consistent with our data because fatty kidney group showed significantly lower LDLC level. Bartelt et al. identified brown adipose tissue as a major organ involved in plasma very light density lipoprotein triglycerides clearance in mice. Cold exposure activated brown adipose tissue significantly lowered level of TG. However, HDLC level slightly increased, which is probably explained by an increase of TG-rich lipoproteins derived HDLC precursors. For further studies we have to detect serum level of uncoupling protein-1 -- a marker of brown adipose tissue.

Our study has limitations. First, we analyzed only serum KIM-1. There are studies that reflect serum KIM-1 as blood marker for early kidney injury detection as mentioned before, however, detection of urine KIM-1 could give more precise results. Second, relatively small number of individuals were included in the follow-up study. Strengths of our study are that volumetric analysis of various adipose tissue segments was carried out. Amount of adipose tissue in the RS was standardized by using corresponding kidney, thus excluding possibility that size of the kidney influence amount of adipose tissue in the RS. Moreover, our results show that it is important to measure the left and the right RS adipose tissue volumes because of significant asymmetrical RS adipose tissue deposition. The research group was selected so that both genders and all BMI groups were evenly represented.

Regardless of gender adipose tissue in RS accumulates asymmetrically -- the left RS accumulates a significantly higher amount of adipose tissue. Thus, primarily RS adipose tissue effects should be assessed on the left kidney. Accumulation of adipose tissue in the RS is related with the visceral adipose amount and KIM-1 concentration increase in the blood serum. Additionally, FGF-21 level is positively associated with the RS and RP adipose tissue amount.
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![Design of the cross-sectional and the prospective one-year naturalistic follow-up study.](gr1){#f0005}

![Abdominal computed tomography scans demonstrating renal sinus and abdominal adipose tissue compartment measurements. a: The levels of abdominal adipose tissue measurements. A-1 -- the level where total abdominal adipose tissue measurements were performed (RP~full,~ IP~full~, SC~full~). A-2 -- the level where abdominal adipose tissue measurements in three axial slices were performed (RP~three-slices,~ IP~three-slices~, SC~three-slices~). The red line represents the boundary of RS; b: Example of single abdominal CT slice selected for RS and abdominal adipose tissue compartment measurements; c: Visualization of RS and abdominal adipose tissue compartments as well as kidney using 3D Doctor software; d: Volumetric right and left RS adipose tissue compartment visualization. e: Measure of the kidney length (pole to pole) (1.) in the sagittal plane and sagittal (2.) as well as lateral diameter (3.) in the axial plane; f: 3D reconstruction of RS, IP, RP, SC and kidneys. RS adipose tissue and kidneys were segmented fully; RP, IP and SC adipose tissue at the renal hilum\'s level. Subcutaneous adipose tissue (SC) (gray); Intraperitoneal (IP) adipose tissue (yellow); RP adipose tissue (purple); Right RS adipose tissue (red); Left RS adipose tissue (green).](gr2){#f0010}

![Gender and topography (right and left kidney) effects on the renal sinus adipose tissue accumulation. \*\*\*, ^\#\#\#^ p \< 0.001; ^++^ p = 0.006, °labels potential extremes. Right and left kidney compared by using Wilcoxon rank-sum test; Male and female groups compared by using Mann-Whitney test. Symbols used in the graph: \*Right RS ratio vs. Left RS ratio (for male and female group, respectively); ^\#^Female right RS ratio vs. Male right RS ratio; ^+^ Female left RS ratio vs. Male left RS ratio. RS~Ratio~ - ratio of RS adipose tissue volume to corresponding total kidney size.](gr3){#f0015}

![Bland and Altman plots of the intra-reader (a) and the inter-reader (b) renal sinus adipose tissue volume measurements. The average of the repeated measurements is presented on the x-axis and the difference between two measurements is presented on y-axis. The middle continuous line represents the mean difference between the repeated measures, upper and lower dotted lines represent upper and lower confidence limits for the mean difference, respectively (*n* = 150 (M/F, 75/75)). The level of significance was set as p \< 0.05.](gr4){#f0020}

![Serum KIM-1 and FGF-21 levels according to left (a and c) or right (b and d) RS ratio quartiles. Male (M) and female (F) were divided into 3 groups based on left or right RS ratio quartiles: \< 25th quartile Q~1~ (F/M; 34/38); 25th--75th inter quartile range Q~2~ + Q~3~ (F/M; 62/60); \> 75th quartile Q~4~ (F/M; 44/42). \*Q~1~ vs. Q~4~; ^\#^Q~2~ + Q~3~ vs. Q~4~; \^Q~1~ vs. Q~2~ + Q~3~. \*, ^\#^, ^\^^p \< 0.05; ^⁎⁎^p \< 0.01; Mann-Whitney *U* test.](gr5){#f0025}

![Left (a) and right (b) renal sinus adipose tissue volumes changes (%) in the one year follow-up period, based on the visceral adipose tissue significant (\> 5%) increase or decrease. The mean value of the time point "Baseline" was arbitrarily set at 100%. p Value shown above the black, blue and red lines represent difference between "Baseline" and "End" (Wilcoxon rank-sum test). p Value which are indicated under the brace represent difference between control group (Mann Whitney *U* test). The level of significance was set as p \< 0.05.](gr6){#f0030}

###### 

General characteristics of cross-sectional study participants and abdominal adipose tissue measurements (n~total~ = 280).

Table 1

  Measurements                                          Control (no fatty kidney) *n* = 199 (F/M; 96/103)   Fatty kidney *n* = 81 (F/M; 44/37)   Age and gender adjusted p
  ----------------------------------------------------- --------------------------------------------------- ------------------------------------ ---------------------------
  Anthropometric parameters                                                                                                                      
  Age, years[a](#tf0005){ref-type="table-fn"}           38.00 (34.00, 40.25)                                38.00 (35.00, 40.00)                 0.116
  BMI, kg/m^2^                                          27.02 (23.98, 30.89)                                30.86 (26.86, 33.35)                 **0.005**
  WC, cm                                                92.00 (82.00, 101.00)                               100.00 (89.00, 105.00)               0.322
  SBP, mm Hg                                            120.00 (110.00, 125.00)                             120.00 (115.00, 129.00)              0.136
  DBP, mm Hg                                            75.00 (70.00, 85.00)                                80.00 (75.00, 85.00)                 0.110
                                                                                                                                                 
  Adipose tissue measurements                                                                                                                    
  RP, cm^3^                                             27.56 (13.33, 54.86)                                52.37 (31.89, 84.53)                 0.175
  IP, cm^3^                                             89.81 (40.94, 168.23)                               171.61 (92.50, 253.49)               0.204
  SC, cm^3^                                             175.41 (111.55, 309.66)                             249.26 (144.34, 340.68)              0.731
  RS~Right~, cm^3^                                      0.39 (0.10, 0.95)                                   2.72 (1.83, 4.89)                    **\< 0.001**
  Right RS~Ratio~                                       0.0026 (0.0007, 0.0061)                             0.0165 (0.0102, 0.0288)              **\< 0.001**
  RS~Left~, cm^3^                                       1.42 (0.57, 2.56)                                   5.20 (4.28, 7.47)                    **\< 0.001**
  Left RS ~Ratio~                                       0.0084 (0.0035, 0.0148)                             0.0329 (0.0258, 0.0464)              **\< 0.001**
                                                                                                                                                 
  Kidney biochemical parameters                                                                                                                  
  sKIM-1, pg/ml                                         110.10 (52.21, 235.14)                              178.26 (115.25, 304.26)              **\< 0.05**
  FGF21, pg/ml                                          106.92 (66.59, 189.40)                              204.26 (76.89, 404.26)               **\< 0.05**
  eGFR~EPI\ cyst&crea,~ ml/min/1.73 m^2^                144.25 (108.37, 121.66)                             110.39 (105.25, 119.04)              0.202
  Cystatin C, mg/l[b](#tf0010){ref-type="table-fn"}     0.69 (0.61, 0.77)                                   0.74 (0.63, 0.81)                    0.200
  Creatinine, μmol/l[b](#tf0010){ref-type="table-fn"}   0.76 (0.68, 0.87)                                   0.80 (0.74, 0.96)                    0.251
                                                                                                                                                 
  Glucose and lipid profile                                                                                                                      
  Glucose, mmol/l                                       5.00 (4.77, 5.35)                                   5.10 (4.80, 5.37)                    0.171
  TG, mmol/l                                            1.06 (0.78, 1.51)                                   1.47 (0.88, 1.94)                    **\< 0.05**
  HDLC, mmol/l                                          1.52 (1.29, 1.77)                                   1.43 (1.09, 1.72)                    0.190
  LDLC, mmol/l                                          3.27 (2.79, 3.95)                                   2.93 (2.44, 3.78)                    **0.017**
  Inflammatory cytokine levels                                                                                                                   
  IL-6, pg/ml                                           1.41 (1.09, 1.77)                                   1.21 (0.89, 1.52)                    0.275
  TNFα, pg/ml                                           2.32 (1.69, 3.74)                                   2.41 (1.94, 3.44)                    0.343

Data are presented as median (25th, 75 percentile) (age and gender adjusted p values calculated by binary logistic regression). BMI - body mass index; WC - Waist circumference; SBP - systolic blood pressure; DBP - diastolic blood pressure; SC -- subcutaneous adipose tissue; IP -- intraperitoneal adipose tissue; RP -- retroperitoneal adipose tissue; RS -- renal sinus adipose tissue; RS~Ratio~ - ratio of RS adipose tissue volume to corresponding total kidney size; sKIM-1 -- serum kidney injury molecule-1; FGF-21 -- fibroblast growth factor -- 21; eGFR~EPI\ cyst&crea~ -- estimated glomerular filtration rate; TG -- triglycerides; HDLC -- high density lipoprotein cholesterol; LDLC - low density lipoprotein cholesterol; IL-6 -- interleukin 6; TNFα - tumor necrosis factor alpha. The level of significance was set as p \< 0.05.

Data show the gender adjusted p value.

Serum cystatin and creatinine were used to estimate GFR.

###### 

A kidney length (pole to pole) in the coronal plane, sagittal and lateral diameter in the axial plane, and a kidney volume.

Table 2

                          Side    Male             p, R vs. L     Female                    p, R vs. L     p, M vs. F
  ----------------------- ------- ---------------- -------------- ------------------------- -------------- --------------
  Kidney lenght, cm       Right   10.48 ± 1.29     0.452          10.50 ± 1.65              0.321          0.921
                          Left    10.89 ± 1.56                    10.56 ± 1.29                             0.845
  Sagittal diameter, cm   Right   5.52 ± 0.68      **\< 0.001**   5.51 ± 0.55               **\< 0.001**   0.973
                          Left    5.15 ± 0.52                     5.03 ± 0.53                              0.174
  Lateral diameter, cm    Right   5.24 ± 0.67      **\< 0.001**   4.77 ± 0.61               **0.002**      **\< 0.001**
                          Left    5.59 ± 0.67                     4.92 ± 0.55                              **\< 0.001**
  Kidney volume, cm^3^    Right   174.96 ± 25.96   0.268          151.19 (137.70, 169.88)   0.175          **\< 0.001**
                          Left    177.51 ± 27.94                  151.34 (134.61, 167.59)                  **\< 0.001**

Median (25th, 75 percentile) for skewed data; Mean with standard deviation (± SD) for normally distributed data. The left (L) and the right (R) kidney is compared by using paired Student\'s t test (normally distributed data) and Wilcoxon rank-sum test (skewed data); Male (M) and female (F) groups are compared by using Mann-Whitney *U* test. The level of significance was set as p \< 0.05.

###### 

Age and gender adjusted partial Pearson correlations (r) with sqrt-transformed left or right RS ratio.

Table 3

                                           sqrt right RS ratio   sqrt left RS ratio            
  ---------------------------------------- --------------------- -------------------- -------- --------------
  Anthropometric parameters                                                                    
  Age[a](#tf0015){ref-type="table-fn"}     0.30                  **\< 0.001**         0.32     **\< 0.001**
  BMI, kg/m^2^                             0.37                  **\< 0.001**         0.36     **\< 0.001**
                                                                                               
  WC, cm                                   0.40                  **\< 0.001**         0.36     **\< 0.001**
  SBP, mm Hg                               0.12                  0.213                0.13     0.104
  DBP, mm Hg                               0.17                  0.088                0.15     0.114
                                                                                               
  Adipose tissue measurements                                                                  
  sqrt RP,cm^3^                            0.60                  **\< 0.001**         0.52     **\< 0.001**
  sqrt IP,cm^3^                            0.50                  **\< 0.001**         0.42     **\< 0.001**
  sqrt SC, cm^3^                           0.40                  **\< 0.001**         0.35     **\< 0.001**
                                                                                               
  Kidney biochemical parameters                                                                
  eGFR~EPI\ cyst&crea,~ ml/min/1.73 m^2^   − 0.10                0.451                − 0.17   0.330
  Cystatin C, mg/l                         0.12                  0.221                0.13     0.193
  Creatinine, μmol/l                       0.02                  0.856                0.04     0.703
  *Sqrt* sKIM-1, pg/ml                     0.49                  **0.040**            0.56     **0.023**
  *Sqrt* FGF21, pg/ml                      0.57                  **0.001**            0.64     **\< 0.001**
                                                                                               
  Glucose and lipid profile                                                                    
  Glucose, mmol/l                          0.03                  0.897                0.06     0.717
  *Sqrt* TG, mmol/l                        0.25                  **0.009**            0.21     **0.033**
  *Sqrt* HDLC, mmol/l                      − 0.04                0.688                − 0.05   0.626
  *Sqrt* LDLC, mmol/l                      − 0.22                **0.024**            − 0.20   **0.038**
                                                                                               
  Inflammatory cytokine levels                                                                 
  *Sqrt* IL-6, pg/ml                       − 0.25                0.107                − 0.05   0.734
  *Sqrt* TNFα, pg/ml                       − 0.10                0.541                − 0.12   0.450

sqrt -- square root-transformation; RS -- renal sinus; SC -- subcutaneous adipose tissue; IP -- intraperitoneal adipose tissue; RP -- retroperitoneal adipose tissue; RS~Ratio~ - ratio of RS adipose tissue volume to corresponding total kidney size; BMI -- body mass index; WC -- waist circumference; SBP - systolic blood pressure; DBP -- diastolic blood pressure; eGFR~EPI\ cyst&crea~ -- estimated glomerular filtration rate; sKIM-1 -- serum kidney injury molecule-1; FGF-21 -- fibroblast growth factor -- 21; TG -- triglycerides; HDLC -- high density lipoprotein cholesterol; LDLC - low density lipoprotein cholesterol; IL-6 -- interleukin 6; TNFα - tumor necrosis factor alpha. The level of significance was set as p \< 0.05.

Data show the gender adjusted partial Pearson correlation.

###### 

General characteristics of follow-up study participants and abdominal adipose tissue measurements (n~total~ = 40).

Table 4

  Measurements      Intervention (text message)   No intervention                                     
  ----------------- ----------------------------- ------------------------- ------------------------- -------------------------
  BMI, kg/m^2^      35.68 ± 4.31                  33.24 ± 3.51              35.86 ± 6.88              34.77 ± 7.37
  WC, cm            107.52 ± 11.37                103.30 ± 9.14             106.71 ± 12.58            102.04 ± 13.82
  RP, cm^3^         76.50 ± 35.02                 74.78 ± 34.89             75.01 ± 30.15             74.51 ± 28.69
  IP, cm^3^         245.94 ± 75.90                238.44 ± 74.66            244.45 ± 69.91            231.06 ± 77.76
  SC, cm^3^         300.05 ± 132.99               280.56 ± 112.77           333.42 ± 174.61           275.88 ± 120.27
  Left RS, cm^3^    3.56 (2.96, 6.95)             3.33 (2.78, 6.37)         3.50 (1.25, 4.09)         3.65 (1.03, 4.01)
  Right RS, cm^3^   3.07 (1.00, 4.56)             2.83 (1.24, 4.65)         3.33 (0.39, 2.62)         2.40 (0.37, 3.11)
  sKIM-1, pg/ml     150.37 (69.39, 290.96)        137.61 (47.67, 238.83)    159.54 (43.41, 197.10)    147.91 (56.26, 184.13)
  FGF-21, pg/ml     198.41 (160.32, 475.06)       177.25 (132.14, 412.11)   209.52 (176.12, 499.27)   180.33 (143.17, 398.19)

Median (25th, 75 percentile) for skewed data; Mean with standard deviation (± SD) for normally distributed data. BMI - body mass index; WC - waist circumference; SC -- subcutaneous adipose tissue; IP -- intraperitoneal adipose tissue; RP -- retroperitoneal adipose tissue; Left RS- left renal sinus adipose tissue; Right RS -- right renal sinus adipose tissue; sKIM-1 -- serum kidney injury molecule-1; FGF-21 - fibroblast growth factor-21.

###### 

Age and gender adjusted partial Person correlations (r) between the left and the right renal sinus adipose tissue and visceral adipose tissue in the one year follow-up study (n~total~ = 40).

Table 5

                               Visceral adipose tissue ~Baseline~, cm^3^   Visceral adipose tissue ~End~, cm^3^      ΔVisceral adipose tissue, %
  ---------------------------- ------------------------------------------- ----------------------------------------- -----------------------------------------
  Right RS ~Baseline~, cm^3^   0.82[⁎⁎⁎](#tf0020){ref-type="table-fn"}                                               
  Left RS ~Baseline~, cm^3^    0.79[⁎⁎⁎](#tf0020){ref-type="table-fn"}                                               
  Right RS ~End~, cm^3^                                                    0.76[⁎⁎⁎](#tf0020){ref-type="table-fn"}   
  Left RS ~End~, cm^3^                                                     0.78[⁎⁎⁎](#tf0020){ref-type="table-fn"}   
  ΔRight RS, %                                                                                                       0.65[⁎⁎⁎](#tf0020){ref-type="table-fn"}
  ΔLeft RS, %                                                                                                        0.71[⁎⁎⁎](#tf0020){ref-type="table-fn"}

Δ -- percentage change from baseline; Left RS - left renal sinus adipose tissue; Right RS -- right renal sinus adipose tissue.

p \< 0.001.

###### 

Spearman correlations between percentage change from baseline for the all adipose tissue segments (ΔSC, ΔIP, ΔRP, Δleft RS and Δright RS adipose tissue), sKIM-1 (ΔsKIM-1) and FGF-21 (ΔFGF-21) level.

Table 6

                             ΔsKIM-1, %   ΔFGF-21, %
  -------------- ----------- ------------ ------------
  ΔRP,%          r           0.19         0.61
  p              0.609       **0.002**    
  ΔIP,%          r           0.21         0.14
  p              0.510       0.110        
  ΔSC, %         r           0.16         0.14
  p              0.667       0.091        
  ΔLeft RS,%     r           0.69         0.47
  p              **0.031**   **0.044**    
  ΔRight RS, %   r           0.61         0.36
  p              **0.039**   0.051        

Δ -- percentage change from baseline; SC -- subcutaneous adipose tissue; IP -- intraperitoneal adipose tissue; RP -- retroperitoneal adipose tissue; Left RS - left renal sinus adipose tissue; Right RS -- right renal sinus adipose tissue; sKIM-1 -- serum kidney injury molecule-1; FGF-21 -- fibroblast growth factor-21. The level of significance was set as p \< 0.05.
